Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

M. Chris Runken, PharmD

Articles by M. Chris Runken, PharmD

Finasteride Versus Dutasteride: A Real-world Economic Evaluation

ByThomas C. Fenter, MD,M. Chris Runken, PharmD,Libby Black, PharmD,Michael Eaddy, PharmD, PhD

February 1st 2007

A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride

ByMuta M. Issa, MD, MBA,M. Chris Runken, PharmD,Amy L. Grogg, PharmD,Manan B. Shah, PharmD, PhD

February 1st 2007

Latest Updated Articles

Finasteride Versus Dutasteride: A Real-world Economic Evaluation
Published: February 1st 2007 | Updated:
A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride
Published: February 1st 2007 | Updated:

Trending on AJMC

Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review

US, Japan Patients With Diabetes Discontinue Semaglutide After First Year

Teclistamab for R/R MM Effective and Safe When Administered in a Community Setting

How Health Systems, Pharmacy Teams Tackle Rare Disease Therapy Barriers: David Mitchell, PharmD, MBA

Childhood Insurance Dynamics Predict Medicaid Cuts Will Widen Gaps

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

© 2025 MJH Life Sciences^®

All rights reserved.